tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Protara Therapeutics (TARA)
NASDAQ:TARA
US Market
TARA
Protara Therapeutics
RESEARCH TOOLSreports

Protara Therapeutics (TARA) Stock News & Sentiment

Compare
1,261 Followers
Protara Therapeutics Raises $86.3 Million in Offering
Premium
Company Announcements
Protara Therapeutics Raises $86.3 Million in Offering
9d ago
8K
TARA
Protara Therapeutics Completes $75 Million Stock Offering
Premium
Company Announcements
Protara Therapeutics Completes $75 Million Stock Offering
16d ago
8K
TARA
Protara’s TARA-002: Promising Efficacy and Clear Regulatory Path Justify Buy Rating
Premium
Ratings
Protara’s TARA-002: Promising Efficacy and Clear Regulatory Path Justify Buy Rating
21d ago
TARA
Buy Rating for Protara Therapeutics Driven by Promising Bladder Cancer Drug Trial
Premium
Ratings
Buy Rating for Protara Therapeutics Driven by Promising Bladder Cancer Drug Trial
21d ago
TARA
Buy Recommendation for Protara Therapeutics Driven by Promising TARA-002 Developments and Strategic Market Positioning
Premium
Ratings
Buy Recommendation for Protara Therapeutics Driven by Promising TARA-002 Developments and Strategic Market Positioning
21d ago
TARA
Protara Therapeutics Announces Promising Phase 2 Trial Results
Premium
Company Announcements
Protara Therapeutics Announces Promising Phase 2 Trial Results
21d ago
8K
TARA
Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC Amidst BCG Shortages
Premium
Ratings
Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC Amidst BCG Shortages
1M ago
TARA
More TARA News >

TARA News on the Web

Why Protara Therapeutics, Inc.’s (TARA) Stock Is Down 5.61%
AAII
Neutral
Protara Therapeutics Completes $75 Million Stock Offering
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Protara Therapeutics (TARA)
TipRanks News
Neutral
Protara Therapeutics Shares Sink 16% After $75 Mln Public Offering
rttnews
Bearish
Protara Secures $75 Million to Advance TARA-002 and Broaden Clinical Pipeline
Market Chameleon
Neutral
Why Protara Therapeutics, Inc.’s (TARA) Stock Is Down 23.18%
AAII
Neutral
TARA-002 Shows 72% Complete Response Rate in BCG-Naive NMIBC Patients—Phase 2 Trial Interim Data Revealed
Market Chameleon
Neutral
TARA-002 Achieves 72% Complete Response Rate in Phase 2 NMIBC Trial, Highlighting Strong Potential in BCG-Naive Patients
Market Chameleon
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TARA’s Media Buzz Sentiment?
Currently, no data Available
What is TARA’s weekly average amount of articles?
Currently, no data Available
What is TARA’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
CYTKCytokinetics
ATAIATAI Life Sciences
JNJJohnson & Johnson
NVONovo Nordisk
PDEXPro-Dex
Showing the stocks with the most bullish news sentiment over the past week